Considering the criticality in respect of Active Pharmaceutical Ingredients (APIs) and Key Starting Material (KSMs), the companies have sta...

We have internal cash generation of about Rs 220 crore annually. Now, this capex of 800 crore is spread out over three years of which 500 c...